STOCK TITAN

Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program

Bausch Health (NYSE:BHC) and Ortho Dermatologics announced the 2026 ASPIRE HIGHER Scholarship Program, awarding six students impacted by dermatologic conditions with scholarships of up to $10,000 each.

(Neutral)
(Neutral)
Tags

Bausch Health (NYSE:BHC) and Ortho Dermatologics announced the 2026 ASPIRE HIGHER Scholarship Program, awarding six students impacted by dermatologic conditions with scholarships of up to $10,000 each. Applications are open through June 10, 2026, and recipients will be notified in July 2026.

Eligible applicants include current or prospective students for the 2026–2027 academic year at two- or four-year colleges, universities, or advanced vocational/technical schools; three undergraduate and three graduate awards will be offered. Applicants must submit an essay and two letters of reference. More details at the program website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.
Argus Mar 26 session
+0.79% close to close Open Argus
Details

News Market Reaction – BHC

On Mar 26, the day this news came out, BHC closed 0.79% above the previous close.

Data tracked by StockTitan Argus for the Mar 26 session.

Market Context

This announcement expands Bausch Health’s patient- and community-focused efforts, offering six derma...
Analysis

This announcement expands Bausch Health’s patient- and community-focused efforts, offering six dermatology-related scholarships of up to $10,000 each for the 2026–2027 academic year. It mirrors earlier initiatives like the GI Health Scholars Program and supports brand visibility in key therapeutic areas. In context of prior product launches and solid $10.27B 2025 revenues, this program underscores a strategy of combining commercial execution with disease-focused outreach. Future updates on franchise performance and continued guidance execution will remain important reference points.

Key Figures

Dermatology scholarships: 6 scholarships Scholarship amount: up to $10,000 each Application deadline: June 10, 2026 +5 more
Dermatology scholarships
6 scholarships
ASPIRE HIGHER 2026 program
Scholarship amount
up to $10,000 each
ASPIRE HIGHER 2026 awards
Application deadline
June 10, 2026
ASPIRE HIGHER 2026 program
Q4 2025 revenue
$2.80 billion
Q4 2025 consolidated revenues
FY 2025 revenue
$10.27 billion
Full-year 2025 consolidated revenues
Q4 2025 GAAP net loss
$112 million
Q4 2025 GAAP results
FY 2025 GAAP net income
$157 million
Full-year 2025 GAAP results
2026 revenue guidance
$10.625–$10.875 billion
Company 2026 outlook

Historical Context

5 past events · Latest: Feb 23
5 events
  1. Feb 23

    Aesthetics product launch

    24h Move
    -2.5%

    Health Canada-approved launch of Clear + Brilliant Touch laser in Canada.

  2. Feb 19

    Product anniversary

    24h Move
    -4.2%

    25th anniversary of ARESTIN with expanded presence in Canada and Puerto Rico.

  3. Feb 18

    Earnings and guidance

    24h Move
    -4.2%

    Q4 and full-year 2025 results with revenue growth and 2026 guidance.

  4. Feb 17

    Conference participation

    24h Move
    +0.0%

    Planned attendance at J.P. Morgan Global Leveraged Finance Conference.

  5. Feb 11

    Scholarship program

    24h Move
    -1.3%

    Launch of Salix GI Health Scholars Program offering 10 scholarships up to $10,000.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

dermatologic conditions
1 terms
dermatologic conditions medical
"students impacted by dermatologic conditions, with applications open through June 2026"
Dermatologic conditions are disorders that affect the skin, hair, nails or related tissues, ranging from common issues like eczema and acne to chronic or severe diseases. They matter to investors because how common these problems are, how well they respond to existing treatments, and any new drugs or devices approved to treat them can change patient demand, company revenues and regulatory risk—much like home repairs driving business for contractors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Bausch Health is offering scholarships to six students impacted by dermatologic conditions, with applications open through June 2026

LAVAL, QC, March 26, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its dermatology business, Ortho Dermatologics, today announced the 2026 ASPIRE HIGHER Scholarship Program, with applications open through June 10, 2026. The program will award six exceptional students, impacted by dermatologic conditions with scholarships of up to $10,000 each to support their pursuit of higher education.

"It is an honor to continue the ASPIRE HIGHER Scholarship Program and support students who have demonstrated resilience while managing dermatologic conditions," said Tom Stern, Vice President and General Manager, Ortho Dermatologics, Bausch Health. "These students inspire us with their determination, and we are proud to recognize their achievements and the healthcare providers who play an important role in their care."

Eligible students may apply by completing an online application, submitting an essay describing the impact of living with a diagnosed dermatologic condition and the role a healthcare provider has played in helping manage their condition, and providing two letters of reference.

Scholarships are available to students who are current or prospective attendees of a two- or four-year college or university, or an advanced vocational or technical school, for the 2026–2027 academic year and are available in the following categories:

  • Three Undergraduate Scholar Awards—for students pursuing undergraduate or vocational/technical degrees
  • Three Graduate Scholar Awards—for students pursuing graduate-level degrees

The application period for the 2026 ASPIRE HIGHER Scholarship Program will close on June 10, 2026, and scholarship recipients will be notified in July 2026.

To learn more about the scholarship program, including eligibility criteria, terms and conditions, and stories from previous recipients, visit www.aspirehigherscholarships.com.

About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. Our dermatology business, Ortho Dermatologics is one of the largest prescription and aesthetic dermatology businesses dedicated to helping patients in the treatment of a range of conditions, including psoriasis, onychomycosis, actinic keratosis, acne, atopic dermatitis and other dermatoses. More information can be found at https://www.ortho-dermatologics.com and connect with us on LinkedIn. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.

© 2026 Ortho Dermatologics or its affiliates


Investor Contact:                                            

Media Contact:

Garen Sarafian                                                            

Katie Savastano

ir@bauschhealth.com                                          

corporate.communications@bauschhealth.com 

877-281-6642 (toll-free)                                      

(908) 569-3692



BHC-ORGANIZATION


 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-announces-ortho-dermatologics-2026-aspire-higher-scholarship-program-302725288.html

SOURCE Bausch Health Companies Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the 2026 ASPIRE HIGHER Scholarship from Bausch Health (BHC)?

It is a scholarship program awarding six students up to $10,000 each. According to the company, three awards target undergraduate/vocational students and three target graduate-level students for the 2026–2027 academic year.

Who is eligible to apply for the ASPIRE HIGHER Scholarship (NYSE: BHC) in 2026?

Eligible applicants are students impacted by diagnosed dermatologic conditions pursuing higher education in 2026–2027. According to the company, applicants may be current or prospective attendees of two- or four-year colleges or advanced vocational/technical schools.

What is the application deadline for Bausch Health's ASPIRE HIGHER Scholarship 2026?

The application period closes on June 10, 2026. According to the company, recipients will be notified in July 2026 and must submit an essay plus two letters of reference as part of the online application.

How much funding does each ASPIRE HIGHER Scholarship award from BHC provide?

Each scholarship is worth up to $10,000 per recipient. According to the company, six total scholarships will be awarded, supporting students affected by dermatologic conditions for the 2026–2027 academic year.

What materials are required to apply for the ASPIRE HIGHER Scholarship (BHC) 2026?

Applicants must complete an online application, submit an essay about living with a dermatologic condition, and provide two letters of reference. According to the company, the essay should describe the role a healthcare provider played in managing the condition.

When will ASPIRE HIGHER Scholarship recipients for 2026 be notified and where to find more information?

Recipients will be notified in July 2026. According to the company, full eligibility criteria, terms, and past recipient stories are available at www.aspirehigherscholarships.com.

Keep reading